Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,101,592

« Back to Dashboard

Which drugs does patent 9,101,592 protect, and when does it expire?

Patent 9,101,592 protects GONITRO and is included in one NDA. There are three tentative approvals for the compound protected by this patent. Additional details are available via the generic ingredient links below.

This patent has nine patent family members in five countries.

Summary for Patent: 9,101,592

Title:Stabilized granules containing glyceryl trinitrate
Abstract: Solid pharmaceutical preparation with the active substance glyceryl trinitrate for oromucosal or oral administration characterized in that it contains between 0.05 and 2 weight % glyceryl trinitrate, at least one carrier material, and at least one substance that reduces the volatility of the GTN, whereby this substance is a non-volatile ester stabilizer.
Inventor(s): Zimmeck; Thomas (Hohenlockstedt, DE), Ueck; Henning (Bekmunde, DE), Gehricke; Julia (Kiel, DE)
Assignee: G. POHL-BOSKAMP GMBH & CO. KG (Hohenlockstedt, DE)
Application Number:14/473,415
Patent Claim Types:
see list of patent claims
Composition; Compound; Formulation; Use; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Pohl Boskamp
POWDER;SUBLINGUAL208424-001Jun 8, 2016RXYesYes9,101,592► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 9,101,592

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany10 2011 012 491Feb 25, 2011

International Patent Family for Patent: 9,101,592

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2012219925► Subscribe
Australia2012219926► Subscribe
Canada2827714► Subscribe
Canada2827716► Subscribe
European Patent Office2678000► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus